Servizio Comunitario di Informazione in materia di Ricerca e Sviluppo - CORDIS

Le informazioni sui progetti di Orizzonte 2020 e ora anche le relative sintesi delle relazioni sono disponibili su CORDIS. Tutti i progetti H2020 possono essere scaricati dal Portale Open Data dell'UE .

My refinements


Download results of this page


Perfeziona per:

Tipo di contenuto

Notizie (22836)
Evento (5547)

Fonte

EC (25809)
WIRE (2573)

Programma

Altro
Tutti
CC-CH-NCCR-NANOSCI (1)
CIP (343)
EAEC-FUSION 12C (6)
EAEC-FWP-EAEC 1C (30)
EAEC-FWP-EAEC 2C (16)
EAEC-JRC-RES 10C (1)
EAEC-NFS 2 (1)
ECSC-COALRES 6C (1)
ECSC-COALRES 7C (20)
ECSC-STEEL C (20)
EMP-ADAPT (10)
EMP-ADAPT-BIS (6)
EMP-BARCELONA 2002C (7)
EMP-EMPLOYMENT (5)
EMP-HORIZON 2 (5)
EMP-INTEGRA (5)
EMP-LISBON 2000C (1)
EMP-NOW 2 (5)
EMP-SME (11)
EMP-YOUTHSTART (5)
ENG-ALTENER 1 (8)
ENG-ALTENER 2 (16)
ENG-ENERGY-FP C (5)
ENG-SAVE 1 (2)
ENG-SAVE 2 (25)
ENG-THERMIE 1 (11)
ENG-THERMIE 2 (8)
ENV-ACE 1 (1)
ENV-ACE 2 (2)
ENV-ACNAT (1)
ENV-ECCP (5)
ENV-ENVAP 5C (46)
ENV-EVAL 2C (2)
ENV-LIFE 3 (6)
ENV-MARCO POLO (1)
ET-ARIANE (1)
ET-COMETT 2 (1)
ET-ERASMUS (1)
ET-EUROTECNET 2 (1)
ET-FORCE (1)
ET-LEONARDO DA VINCI 1 (41)
ET-LEONARDO DA VINCI 2 (11)
ET-LINGUA (1)
ET-SOCRATES 1 (40)
ET-SOCRATES 2 (10)
ET-TEMPUS 3 (6)
ET-YFE 3C (29)
FP1-AGRIRES 3C (1)
FP1-BAP (1)
FP1-BRITE (1)
FP1-ENVIRO 4C (6)
FP2-AERO 0C (1)
FP2-AIM 1 (1)
FP2-BRIDGE (6)
FP2-BRITE/EURAM 1 (10)
FP2-ECLAIR (1)
FP2-EURET (1)
FP2-FAR (1)
FP2-FAST 3 (5)
FP2-FRAMEWORK 2C (1)
FP2-JOULE 1 (1)
FP2-MHR 4C (1)
FP2-MONITOR (7)
FP2-RADWASTOM 4C (1)
FP2-SAST (1)
FP2-SCIENCE (3)
FP2-SPEAR (1)
FP3-AERO 1C (1)
FP3-AIM 2 (1)
FP3-AIR (1)
FP3-BRITE/EURAM 2 (12)
FP3-CRAFT (9)
FP3-DELTA 2 (1)
FP3-ENV 1C (11)
FP3-ESPRIT 3 (3)
FP3-FRAMEWORK 3C (26)
FP3-HCM (5)
FP3-JOULE 2 (4)
FP3-LIBRARIES (1)
FP3-LRE (1)
FP3-MAT (1)
FP3-NFS 1 (1)
FP3-RACE 2 (2)
FP3-TELEMATICS 1C (5)
FP3-VALUE 2 (8)
FP4 (316)
FP4-ACTS (14)
FP4-BIOMED 2 (9)
FP4-BIOTECH 2 (17)
FP4-BRITE/EURAM 3 (39)
FP4-BSE C (6)
FP4-ENV 2C (23)
FP4-ESPRIT 4 (28)
FP4-ESSI 2 (5)
FP4-FAIR (23)
FP4-INCO (33)
FP4-INNOVATION (93)
FP4-JOULE/THERMIE (16)
FP4-JRC-CEO 2C (5)
FP4-JRC-ENVCLIMAT C (1)
FP4-JRC-RES 9C (14)
FP4-MAST 3 (30)
FP4-NNE-JOULE C (5)
FP4-NNE-THERMIE C (5)
FP4-SMT (11)
FP4-TELEMATICS 2C (33)
FP4-TMR (38)
FP4-TRANSPORT (48)
FP4-TSER (49)
FP4-TSME C (22)
H2020-EU.1.4.
H2020-EU.2.1.1.
H2020-EU.2.1.1.3.
H2020-EU.2.1.2.
H2020-EU.3.1.
H2020-EU.3.4.
H2020-EU.3.6.
HS-EAHSW C (2)
HS-EURAIDS 2C (1)
HS-EURCAN 2C (1)
HS-HEALTH C (2)
HS-TIDE 1 (5)
HS-WOHESAFE 4C (2)
IC-AIDSDC C (1)
IC-AL-INVEST (2)
IC-ALFA (1)
IC-ALURE (1)
IC-ASIA-INVEST (1)
IC-ASIA-ITC (1)
IC-AVICENNE (1)
IC-COST (59)
IC-ENVDC C (1)
IC-EUREKA (131)
IC-IMS (5)
IC-INTAS (23)
IC-ISTC (8)
IC-MED-TECHNO (1)
IC-MEDA (25)
IC-PECO/COPERNICUS (2)
IC-PHARE (61)
IC-SCICOOP-ISR 1C (6)
IC-SCICOOP-SA C (13)
IC-SYNERGY 0 (2)
IC-SYNERGY 1 (8)
IC-TACIS 2 (24)
IC-TACIS 3 (10)
IC-TROPFOREST C (1)
IS-ECONTENT (72)
IS-EEUROPE 2005 (6)
IS-G7-GOVERNMENT C (1)
IS-HDTV C (2)
IS-IDA (5)
IS-INFO2000 (3)
IS-INFORMATION SOCIETY (28)
IS-INFOSEC (1)
IS-ISPO (18)
IS-MLIS (4)
IS-RISO C (3)
IS-SAFER INTERNET PLUS (2)
IS-SPRINT 1 (2)
IS-TEN-ISDN (19)
IS-TEN-TELECOM C (20)
JRC-ENDWEL C (6)
JRC-RES 5C (2)
JRC-RES 6C (2)
JRC-RES 7C (2)
JRC-RES 8C (2)
NAT-AT-FACTOM (1)
NAT-AT-FWF-NANO (2)
NAT-AT-IMO (1)
NAT-AT-NANO (2)
NAT-BE-FNRS-NANO (1)
NAT-BE-NANO (2)
NAT-BE-NANOTECH3 (2)
NAT-CH-TOP NANO21 (1)
NAT-DE-MIKRONANO (2)
NAT-DE-NANO-PROD (1)
NAT-DK-NANO (1)
NAT-FR-NANOSCIENCES (3)
OTH-ARGO (1)
OTH-DCI (1)
OTH-DISEASE C (1)
OTH-ECONTENTPLUS (1)
OTH-EIT (227)
OTH-ERA (2771)
OTH-ERA-NET PLUS (1)
OTH-ESFRI (32)
OTH-EUROPARTENARIAT (3)
OTH-GALILEO (25)
OTH-LISBON STRATEGY (274)
OTH-MEDIA 1 (4)
OTH-MEDIA 2 (2)
OTH-NONFOOD C (1)
OTH-SECURITY (68)
OTH-SMEAP 2C (6)
OTH-SMEAP 3C (19)
OTH-STOA (11)
OTH-TECHNOLOGY PLATFORMS (215)
OTH-TEN-ENERGY C (6)
OTH-TEN-TRANSPORT C (28)
PRE-AGRIRES 0C (1)
PRE-AGRIRES 1C (1)
PRE-AGRIRES 2C (1)
PRE-ENVIRO 1C (2)
PRE-FAST 1 (2)
PRE-FAST 2 (4)
PRE-FUSION 3C (1)
REG-ERDF-INNOVATION C (1)
REG-INTEREG 3C (7)
REG-INTERREG 2 (12)
REG-INTERREG 2 C (15)
REG-INTERREG 3 (7)
REG-JASPERS (1)
REG-JEREMIE (1)
REG-JESSICA (1)
REG-KNOWREG (7)
REG-KONVER 2 (5)
REG-LEADER + (1)
REG-LEADER 1 (3)
REG-LEADER 2 (5)
REG-RECHAR 2 (6)
REG-REGIS 2 (7)
REG-RESIDER 2 (6)
REG-RETEX (5)
REG-TELEMATIQUE (1)
REG-URBAN (8)
SOC-POLLUTION C (5)

Paese

Afghanistan (2)
Austria (89)
Belgio (764)
Brasile (2)
Bulgaria (8)
Cina (1)
Cipro (1)
Croazia (1)
Danimarca (69)
Estonia (4)
Etiopia (6)
Finlandia (17)
Francia (133)
Germania (334)
Giappone (1)
Giordania (6)
Grecia (24)
Irlanda (91)
Israele (10)
Italia (367)
Lettonia (8)
Lituania (1)
Lussemburgo (29)
Malta (1)
Moldova (1)
Norvegia (11)
Nuova Zelanda (2)
Paesi Bassi (55)
Polonia (17)
Portogallo (16)
Regno Unito (150)
Repubblica ceca (14)
Romania (9)
Russia (1)
Singapore (6)
Slovacchia (6)
Slovenia (8)
Spagna (109)
Stati Uniti (1)
Svezia (16)
Svizzera (48)
Turchia (8)
Ungheria (36)

Lingua

Deutsch (4814)
English (7442)
Español (4421)
Français (4691)
Italiano (4415)
Polski (2600)

Advanced search

Results 1 - 10 of 28383
Results/page:
12 3 4 5 6 7 8 9 10 > >| 
Nuevos anticuerpos podrían facilitar tratamientos contra el dengue y el Zika
Más allá de que ambos son virus de ARN transmitidos por mosquitos, el dengue y el Zika comparten otras características: los dos pertenecen al género de los flavivirus y poseen proteínas de envoltura similares. Gracias a una investigación europea conjunta y cofinanciada por el proyecto DENFREE, ahora resulta posible tratar estos dos virus con los mismos anticuerpos.
Programme: FP7-HEALTH
Record Number: 125719
Last updated on: 2016-07-06
Available languages: DE, EN, ES, FR, IT, PL
Newly found antibodies could lead to treatment against both dengue and Zika viruses
Other than both being RNA viruses transmitted by mosquitoes, the dengue and Zika viruses have a few things in common: they both belong to the Flavivirus genus and share similar envelope proteins. Thanks to joint European research, partially funded under the DENFREE project, they can now also be treated with the same antibodies.
Programme: FP7-HEALTH
Record Number: 125719
Last updated on: 2016-07-06
Available languages: DE, EN, ES, FR, IT, PL
Des anticorps récemment découverts pourraient conduire au traitement des virus de la dengue et Zika
Les virus de la dengue et Zika, virus à ARN transmis par les moustiques, présentent quelques points communs: ils appartiennent au genre flavivirus et partagent des protéines d'enveloppe similaires. Grâce à la recherche européenne conjointe, en partie financée par le projet DENFREE, ils peuvent désormais être traités avec les mêmes anticorps.
Programme: FP7-HEALTH
Record Number: 125719
Last updated on: 2016-07-06
Available languages: DE, EN, ES, FR, IT, PL
Nowo odkryte przeciwciała mogą posłużyć za podstawę terapii przeciw wirusom denga i Zika
Poza tym, że obydwa są wirusami RNA przenoszonymi przez komary, wirusy denga i Zika mają kilka innych cech wspólnych: obydwa należą do flawiwirusów i mają podobne białka otoczkowe. Dzięki wspólnemu, europejskiemu przedsięwzięciu badawczemu, finansowanemu częściowo z projektu DENFREE, mogą być teraz leczone za pomocą tych samych przeciwciał.
Programme: FP7-HEALTH
Record Number: 125719
Last updated on: 2016-07-06
Available languages: DE, EN, ES, FR, IT, PL
Anticorpi scoperti di recente potrebbero portare alla cura delle malattie da virus dengue e Zika
Oltre ad essere entrambi virus RNA trasmessi dalle zanzare, i virus dengue e Zika hanno alcune cose in comune: appartengono al genere Flavivirus e condividono proteine involucro simili. Grazie alla ricerca europea congiunta, parzialmente finanziata nell’ambito del progetto DENFREE, le malattie causate dai due virus possono ora essere trattate con gli stessi anticorpi.
Programme: FP7-HEALTH
Record Number: 125719
Last updated on: 2016-07-06
Available languages: DE, EN, ES, FR, IT, PL
Neue Antikörper zur Behandlung von Dengue- und Zika-Viren
Dengue- und das Zika-Viren sind nicht nur beides RNA-Viren, die durch Moskitos übertragen werden, sie zeichnen sich auch durch weitere Gemeinsamkeiten aus: Beide zählen zu den Flaviviren und verfügen über ähnliche Hüllproteine. Dank der gemeinsamen europäischen Forschung, die unter dem Projekt DENFREE teilfinanziert wurde, könnten sie nun auch mit denselben Antikörpern behandelt werden.
Programme: FP7-HEALTH
Record Number: 125719
Last updated on: 2016-07-06
Available languages: DE, EN, ES, FR, IT, PL
Data di inizio: 2016-06-01, Termine: 2016-06-03
El II Congreso Internacional de RICOMET (Second International Conference on Risk Perception, Communication and Ethics of Exposures to Ionising Radiation, RICOMET) se celebrará del 1 al 3 de junio de 2016 en Bucarest, Rumanía.
Programme: H2020
Record Number: 142681
Last updated on: 2016-02-03
Available languages: DE, EN, ES, FR, IT, PL
Data di inizio: 2016-06-01, Termine: 2016-06-03
The Second International Conference on Risk Perception, Communication and Ethics of Exposures to Ionising Radiation (RICOMET) will take place from 1 to 3 June 2016 in Bucharest, Romania.
Programme: H2020
Record Number: 142681
Last updated on: 2016-02-03
Available languages: DE, EN, ES, FR, IT, PL
Data di inizio: 2016-06-01, Termine: 2016-06-03
La seconde conférence internationale sur la perception des risques, la communication et l'éthique des expositions au rayonnement ionisant (RICOMET) se déroulera du 1er au 3 juin à Bucarest, Roumanie.
Programme: H2020
Record Number: 142681
Last updated on: 2016-02-03
Available languages: DE, EN, ES, FR, IT, PL
Data di inizio: 2016-06-01, Termine: 2016-06-03
Druga międzynarodowa konferencja RICOMET (Risk Perception, Communication and Ethics of Exposures to Ionising Radiation) odbędzie się w dniach 1-3 czerwca 2016 r. w Bukareszcie, Rumunia.
Programme: H2020
Record Number: 142681
Last updated on: 2016-02-03
Available languages: DE, EN, ES, FR, IT, PL
12 3 4 5 6 7 8 9 10 > >| 
List retrieved on: 2016-12-11